-
Sentiment for
$ENLV out of 12 total scores; 83 % is positive and 17 % is negative.#sentimenthttps://blueequity.io/symbol/ENLV/Sentiment … -
Biotech updates 11/20:
$ALNY givosiran FDA approval +11%$CORT patent review -22% Offerings$ENLV$GNPX$MTEM$OPTN$OSMT PDUFA July 16$KZIA +130%;$ARAV +44% Pipeline updates$BMY$HTBX$IDYA$NTGN$SBPH$SRRAhttps://www.biopharmcatalyst.com/news/2019/alnylam-alny-receives-early-fda-approval-for-givosiran-corcept-cort-shares-fall-on-patent-review … -
$VERB THIS IS ONE HELLUVA GIFT--BUYING 5 YEAR LOWS
RSI=46
PATENT PENDING--DISRUPTIVE TECH THAT RIVALS $ZM AND HUGE BIG TECH INTEGRATIONS
OVER 60 MLM CLIENTS WITH RECURRING REVENUE AND BACKLOG
$HEPA$ARAV$GE$AMTD$CRM$ENLV$AAPL$CVSI$FNMA$CYAD$CRON$JD$EYEGpic.twitter.com/FW4NgHqVHyVERB THE ULTIMATE BOTTOM PLAY--SEVERELY UNDERVALUEDYOU NEED TO SEE WHY MICROSOFT, ORACLE, SALESFORCE, ADOBE, MARKETO. ODOO AND OTHER BIG TECH HAS ALREADY PARTNERED WITH VERB BIG "GLITCH" --RECENT ACCRETIVE ACQUISITION (SOUND CONCEPTS) NOT PRICED IN -
Biotech updates 11/21:
$GLYC data delay -17%$AZN Calquence FDA Approval Intra-day offerings$ONTX -46%;$BPTH -22%$ENLV withdraws offering Pipeline updates$BIIB$ENTA$ENTX$IMRN$IOVA$SNY$TNXP$XERShttps://www.biopharmcatalyst.com/news/2019/glycomimetics-glyc-shares-fall-17-on-data-delay-intra-day-offerings-for-ontx-and-bpth … -
Enlivex Therapeutics Ltd.
$ENLV Sees Large Increase in Short Interest http://weekherald.com/?p=4106105 -
$NIO Just in case you missed my weekend post, this one goes HIGHER !!! http://ac-investor.blogspot.com/2020/01/here-are-few-trade-ideas-for-this-week.html … Im trying to add more$JAN and$ENLV (rose 8% in Israel) -
Zacks: Brokerages Set $20.00 Target Price for Enlivex Therapeutics Ltd.
$ENLV http://www.dailypolitical.com/?p=3334884 -
HC Wainwright Begins Coverage on Enlivex Therapeutics
$ENLV http://www.dailypolitical.com/?p=3319833 -
Enlivex Therapeutics
$ENLV Upgraded to Buy by ValuEngine http://dispatchtribunal.com/?p=3235467 -
-$0.25 EPS Expected for Enlivex Therapeutics Ltd.
$ENLV This Quarter http://thelincolnianonline.com/?p=3411935 -
Enlivex Therapeutics Ltd.
$ENLV Short Interest Up 11.1% in January http://weekherald.com/?p=4151416 -
Enlivex Therapeutics Ltd.
$ENLV Receives Consensus Rating of “Strong Buy” from Analysts http://weekherald.com/?p=4147718 -
Biotech coverage (NYSE: ATNM) Announces collaboration w/UC Davis and a potential cure for HIV - https://mailchi.mp/broadstreetalerts/we-believe-this-will-be-another-potential-triple-digit-gainer-90569?e=[UNIQID …]
#biotech,#biotechstocks,$CTXR,$TTNP,$DARE,$ACST,$ADAP,$AMRN,$VBIV,$MREO,$BCDA,$VRNA,$BCDA,$CFRX,$ENLV,$BTAI,$ARDS,$NSTG,$OBSV,$GILD,$AMGN
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.